04-04-2020, 09:03 PM
(This post was last modified: 04-04-2020, 10:09 PM by chuck white. Edited 3 times in total.)
Quote:he initial results from a placebo-controlled trial of hydroxychloroquine for COVID-19 indicate that patients hospitalized with mild illness recovered more quickly with addition of the drug than with placebo at the start of a standard treatment. The results also suggest that hydroxychloroquine might convey some protection against the illness worsening.https://www.contagionlive.com/news/resul...or-covid19
Zhan Zhang, MD, of Renmin Hospital of Wuhan University, Wuhan, China, and colleagues reported results from 62 patients randomized to receive either placebo or hydroxychloroquine 200mg twice daily for 5 days on admission in addition to standard treatment consisting of oxygen therapy, and unspecified regimens that could include antiviral and antibacterial agents, and immunoglobulin with or without corticosteroids....
The trial is 1 of 23 that are, or will be testing hydroxychloroquine or chloroquine against COVID-19 on the Chinese Clinical Trial Registry. Of these, 18 are randomized controlled trials of the agent for acute treatment, not in combination with an antibiotic.
Quote:On Saturday the Food and Drug Administration approved the use of two antimalarial drugs, hydroxychloroquine and a related medication, chloroquine, for emergency use to treat COVID-19. The drugs were touted by President Trump as a “game changer” for COVID-19.
However, a study just published in a French medical journal provides new evidence that hydroxychloroquine does not appear to help the immune system clear the coronavirus from the body. The study comes on the heels of two others - one in France and one in China - that reported some benefits in the combination of hydroxychloroquine and azithromycin for COVID-19 patients who didn’t have severe symptoms of the virus.
https://news.yahoo.com/small-trial-finds...54137.html